Maximilian A. Schwarz

First check deep-tech investor

📍 Germany🔄 Updated September 2026💼 25 investments📅 6 years investing🗓 Last invested Oct 2025
VC🌍 Germany20+ investmentsInvested this year
25
Total investments
14
Early stage
1
Mid stage
0
Late stage
6y
Years active

Portfolio

25 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor & Board Observer
Oct 2025
Telura is a deep-tech company enabling geothermal energy everywhere through next-generation drilling. Building on over two decades of research from Europes top technical universities, Teluras electric impulse drilling technology uses high-voltage pulses to break rock from within. This approach enables faster, more cost-efficient access to geothermal resources. Our mission is to power a secure energy supply and enable energy sovereignty.
First check investor
Apr 2025
At Koppie were trying to save your coffee ritual! *stares at half-finished cup, questioningly* Thats right... save your coffee ritual. In short: as a result of global warming, significant demand-supply imbalances are going to be shaking up coffees future. Our typical playbook of solutions, well, theyll not suffice, or they arent desirable (like even more deforestation, mass fertiliser use, industrialised farming vs. local farmers, etc.). To help save your morning ritual, were building a bold brew based on patent pending fermentation & roasting technology. We leverage local pulses to create our "Koppie Bean". A bean you can swap for your coffee bean, and use it whichever way you like. Simple, 100% natural, and actually darn tasty... A little bit Koppie-curious? Send us a message, or sign up to our waitlist at www.koppie.eu. Looking forward to having a sip together!
First check investor
Nov 2024
We created Sam, the AI Data Scientist for Bio, which structures, analyzes, and uncovers new insights in your research data, dramatically enhancing your R&D capabilities.
First check investor
Nov 2023
At Evolv, we believe everyone deserves proven, effective solutions for health and longevity, without the barriers of cost or complexity. In a world where the status quo of weight loss and hair growth solutions revolve around expensive, invasive, confusing and often inaccessible options, Evolv offers an alternative: effective, science-backed health products that empower people to take control of their well-being and healthspan without stigma or complexity. We believe that optimizing your health should start with proactive, preventative care. Evolv brings premium and accessible solutions rooted in cutting-edge molecular science, giving everyone the power to feel better, live longer, and thrive in their everyday lives. Our message is simple: We’re not just another supplement brand; we’re here to disrupt the outdated narratives around weight loss and wellness by offering effective, easy-to-integrate solutions that actually work and put you back in control of your health.
First check investor
Jul 2023
Our mission at Biographica is to accelerate crop improvement, to feed a growing population on a changing planet. The world is facing a food security crisis. We must produce more food in the next 50 years than in the previous 10,000 combined - and at a time when climate change is reducing crop productivity. Gene-editing represents a significant opportunity to address this challenge, by enabling rapid and precise enhancement of crop varieties. However, identifying which genes to edit and how remains a major bottleneck, costing millions of dollars, taking over 2 years, and failing more than 95% of the time. At Biographica were revolutionising this process, by harnessing recent developments in gene-editing, high-throughput sequencing and biology-aware machine learning. Our platform combines graph ML-based, in silico modelling with in vivo validation to rapidly pinpoint genomic modifications that can improve any trait, in any crop. Gene-editing is the future of food. With our platform, we intend to become the gene discovery engine behind the crops of the future. For any enquiries reach out at hello@graphica.bio, and explore our open roles at: https://biographica.recruit.charliehr.com/careers
First check investor
Apr 2023
atmio is building the operating system for the oil & gas sector to effortlessly find, fix, and report methane emissions. With its unique combination of hardware and software, atmio is on a mission to tackle climate change and become the worlds leading provider to measure and manage greenhouse gas emissions.
First check investor
Apr 2023
Aspyre Foods is a climate-focused biotech startup on a mission to produce affordable, indistinguishable and planet-friendly dairy proteins, using molecular farming.
Investor
Nov 2022
Built by biologists, for biologists. Trilobio’s unified robotics, lab device, and software platform is coupled with an app store that packages and distributes lab protocols as code to enable the broad deployment of fully automated labs and address existing data quality and reproducibility challenges.
First check investor & Board Observer
Sep 2022
For too long, have we relied on vast tracts of land to grow our food. Weve plowed and tilled the earth, destroyed the soil and torn up forests to make room for (animal) agriculture. This unchecked and unsustainable expansion of our food system has led to a devastating loss of biodiversity on our planet, with countless species facing extinction as a result of the destruction of their natural habitats. This ends now. Lets decouple food production from agricultural land and rewild back our planet.
First check investor
Jun 2022
We are on a mission to build the climate OS of the food industry. At the end of the day, we exist to help companies across the Ag value chain make more sustainable business decisions that will get them to Net Zero on time.
First check investor
May 2022
We are a consumer facing food-tech company using the power of plant protein and biotechnology to deliver the next generation of delicious and sustainable seafood. Our mission is to bring balance back into our food system by offering delicious and healthy seafood alternatives.
First check investor
Apr 2022
At Officinae Bio were developing a platform to support the future of biologically designed therapeutics. By developing breakthroughs in AI-enabled methodologies for nucleic manufacture we’re supporting pioneering research in Gene-modified Cell therapy, Gene therapy and RNA therapeutic research. DNA platform An automated platform for streamlined development of plasmids and libraries for viral vector and mRNA. RNA platform Our industry leading mRNA development and manufacturing solutions support rapid turnaround, advanced transcription capabilities and precision control over regulatory sequences design.
First check investor
Mar 2022
Concert Bio helps growers harness their microbiome. We combine monitoring with analytics to develop interventions that improve the microbiome that matters to you. Our pilot program for soilless agriculture growers is currently live and accepting partners, see website for details.
Investor
Feb 2022
Investor & Board Observer
Dec 2021
At Rhizocore, we develop technologies to grow symbiotic fungi that enhance the growth, resilience, and carbon sequestration potential of newly planted forests and woodlands. Whether it is for woodland restoration, commercial productivity, increasing tolerance to environmental stresses or capturing more carbon, our unique approach for growing locally-sourced mycorrhizal fungi ensures local adaptability to suit our customers sites and needs. For more information email: info@rhizocore.com
Show all 25 investments ↓
Experience · 33 entries
All (33)
Investments (25)
Founder (1)
Board (6)
2025
Investor & Board Observer
Oct 2025
Telura is a deep-tech company enabling geothermal energy everywhere through next-generation drilling. Building on over two decades of research from Europes top technical universities, Teluras electric impulse drilling technology uses high-voltage pulses to break rock from within. This approach enables faster, more cost-efficient access to geothermal resources. Our mission is to power a secure energy supply and enable energy sovereignty.
First check investor
Apr 2025
At Koppie were trying to save your coffee ritual! *stares at half-finished cup, questioningly* Thats right... save your coffee ritual. In short: as a result of global warming, significant demand-supply imbalances are going to be shaking up coffees future. Our typical playbook of solutions, well, theyll not suffice, or they arent desirable (like even more deforestation, mass fertiliser use, industrialised farming vs. local farmers, etc.). To help save your morning ritual, were building a bold brew based on patent pending fermentation & roasting technology. We leverage local pulses to create our "Koppie Bean". A bean you can swap for your coffee bean, and use it whichever way you like. Simple, 100% natural, and actually darn tasty... A little bit Koppie-curious? Send us a message, or sign up to our waitlist at www.koppie.eu. Looking forward to having a sip together!
2024
First check investor
Nov 2024
We created Sam, the AI Data Scientist for Bio, which structures, analyzes, and uncovers new insights in your research data, dramatically enhancing your R&D capabilities.
2023
First check investor
Nov 2023
At Evolv, we believe everyone deserves proven, effective solutions for health and longevity, without the barriers of cost or complexity. In a world where the status quo of weight loss and hair growth solutions revolve around expensive, invasive, confusing and often inaccessible options, Evolv offers an alternative: effective, science-backed health products that empower people to take control of their well-being and healthspan without stigma or complexity. We believe that optimizing your health should start with proactive, preventative care. Evolv brings premium and accessible solutions rooted in cutting-edge molecular science, giving everyone the power to feel better, live longer, and thrive in their everyday lives. Our message is simple: We’re not just another supplement brand; we’re here to disrupt the outdated narratives around weight loss and wellness by offering effective, easy-to-integrate solutions that actually work and put you back in control of your health.
First check investor
Jul 2023
Our mission at Biographica is to accelerate crop improvement, to feed a growing population on a changing planet. The world is facing a food security crisis. We must produce more food in the next 50 years than in the previous 10,000 combined - and at a time when climate change is reducing crop productivity. Gene-editing represents a significant opportunity to address this challenge, by enabling rapid and precise enhancement of crop varieties. However, identifying which genes to edit and how remains a major bottleneck, costing millions of dollars, taking over 2 years, and failing more than 95% of the time. At Biographica were revolutionising this process, by harnessing recent developments in gene-editing, high-throughput sequencing and biology-aware machine learning. Our platform combines graph ML-based, in silico modelling with in vivo validation to rapidly pinpoint genomic modifications that can improve any trait, in any crop. Gene-editing is the future of food. With our platform, we intend to become the gene discovery engine behind the crops of the future. For any enquiries reach out at hello@graphica.bio, and explore our open roles at: https://biographica.recruit.charliehr.com/careers
Show all 33 entries ↓
Investment activity
2020–2025 · 25 investments
202022021920227202342024120252
Recent (last 2 years)Earlier